BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1019658)

  • 1. Multiple myeloma on polycythemia vera following radioactive phosphorus therapy.
    West WO
    South Med J; 1976 Nov; 69(11):1516-7. PubMed ID: 1019658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Remission incidence and adverse effects in low-dosage radioactive phosphorus therapy of polycythemia vera].
    Hauswaldt C; Horejschi J; Emrich D; Heckner F; Douwes FW; Ziesemer G
    Verh Dtsch Ges Inn Med; 1975; 81():1128-30. PubMed ID: 1229414
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of radioactive phosphorus in the therapy of leukemia, polycythemia vera and lymphomas: a report of 10 years' experience.
    CHODOS RB; ROSS JF
    Ann Intern Med; 1958 May; 48(5):956-77. PubMed ID: 13534214
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transition of polycythemia vera into acute or chronic granulocytic leukemia in the course of treatment with radioactive P-32].
    Kraśnik W
    Pol Tyg Lek; 1975 Feb; 30(6):233-6. PubMed ID: 1054155
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacious treatment of a fatal blood disease: polycythemia vera].
    Sánchez Fayos J; Román Barbero A; Nevado Reviriego I
    Sangre (Barc); 1997 Jun; 42(3):215-8. PubMed ID: 9381264
    [No Abstract]   [Full Text] [Related]  

  • 7. [Association of polycythemia vera and multiple myeloma. Presentation ofa new case and review of the literature].
    Prósper F; Paloma MJ; Rifón J; Cuesta B; Hermida J; Rocha E
    Sangre (Barc); 1993 Dec; 38(6):497-9. PubMed ID: 8171387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with radioactive phosphorus of patients with polycythemia vera and lymphogranulomatosis].
    MAKLETSOVA NP
    Med Radiol (Mosk); 1960 May; 5():26-9. PubMed ID: 14420168
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of 32 phosphorus (32P) in the treatment of polycythemia vera.
    Parmentier C; Gardet P
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):189-92. PubMed ID: 8036140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
    Najean Y; Rain JD; Dresch C; Goguel A; Lejeune F; Echard M; Grange MJ
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():111-9. PubMed ID: 8951781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Previous results in the treatment of polycythemia vera with a radioactive phosphorus isotope P32].
    KRASNIK W; GEMBICKI M; MAGAS S
    Pol Tyg Lek; 1961 May; 16():786-9. PubMed ID: 13754006
    [No Abstract]   [Full Text] [Related]  

  • 12. The incidence of leukaemia in patients with polycythaemia vera treated by radioactive phosphorus.
    LEDLIE EM
    Clin Radiol; 1960 Apr; 11():130-3. PubMed ID: 14415154
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of P32 in the treatment of polycythemia vera].
    TAMASI K; BURGER T
    Orv Hetil; 1961 Mar; 102():599-601. PubMed ID: 13775089
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathological significance of blood volume changes in untreated polycythemia vera and after P32 therapy].
    BURGER T; KESZTHELYI B; PEER J
    Pathol Biol; 1962 Feb; 103():357-60. PubMed ID: 13874809
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of polycythemia vera: use of 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age. The French Polycythemia Study Group.
    Najean Y; Rain JD
    Blood; 1997 Apr; 89(7):2319-27. PubMed ID: 9116275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.
    Berk PD; Goldberg JD; Silverstein MN; Weinfeld A; Donovan PB; Ellis JT; Landaw SA; Laszlo J; Najean Y; Pisciotta AV; Wasserman LR
    N Engl J Med; 1981 Feb; 304(8):441-7. PubMed ID: 7005681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematology clinics. II. The treatment of polycythemia vera with radiophosphorus.
    NORCROSS JW; WARD CL
    Lahey Clin Bull; 1959; 11():155-9. PubMed ID: 14427558
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with radioactive phosphorus therapy in cases of polycythemia vera (author's transl)].
    Meuret G; Hoffmann G; Gmelin R
    Strahlentherapie; 1975 Jan; 149(1):49-54. PubMed ID: 1124554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiophosphorus therapy of polycythemia vera].
    Hör G; Pabst HW
    Ther Umsch; 1973 Nov; 30(11):789-96. PubMed ID: 4591693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.